checkAd

    DGAP-News  145  0 Kommentare CureVac : CureVac Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate, CVnCoV - Seite 5

    For further information, please reference the company's reports and documents filed with the U.S. Securities and Exchange Commission (SEC). You may get these documents by visiting EDGAR on the SEC website at www.sec.gov.


    23.10.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.dgap.de

    Lesen Sie auch

    1142776  23.10.2020 

    fncls.ssp?fn=show_t_gif&application_id=1142776&application_name=news&site_id=wallstreet
    Seite 5 von 5




    EQS Group AG
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Verfasst von EQS Group AG
    DGAP-News CureVac : CureVac Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate, CVnCoV - Seite 5 DGAP-News: CureVac / Key word(s): Study CureVac : CureVac Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate, CVnCoV 23.10.2020 / 13:15 The issuer is solely responsible for the content of this announcement. CureVac Reports …